Parmis, Viviana L.

HRN: 17-43-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
CEFTRIAXONE 1G (VIAL)
05/25/2023
06/01/2023
IV
2g
OD
Complicated UTI
Checking Final Appropriateness 
05/29/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/29/2023
06/08/2023
IV
500mg
TID
Empiric
Checking Final Appropriateness 
06/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/01/2023
06/01/2023
IV
4.5gm
LD
Septicemia
Waiting Final Action 
06/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/01/2023
06/07/2023
IV
2.25gm
Q8
Septicemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: